CSTL: Total pendapatan perusahaan Castle Biosciences, Inc.

Castle Biosciences demonstrates high macro resilience due to insurance coverage for its tests, which eliminates seasonality. This chart in the GURU.Markets interface displays the company's sales financial results, where the 0.38 level represents the current value. Growth is supported by close collaboration with oncologists and the effective commercialization of products under stable management.

Pendapatan lan volume dodolan Castle Biosciences (CSTL): kanggo periode 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis Castle Biosciences, Inc. (CSTL)

- kuotasi lan prakiraan analis:

Bagan rega Castle Bio|CSTL - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar Castle Biosciences, Inc.|CSTL - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Saham Castle Biosciences|CSTL - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku castlebiosciences.com|CSTL - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Koefisien Total Utang marang Modal Castle Biosciences|CSTL - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Castle Biosciences Inc|CSTL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Castle Biosciences, Inc.|CSTL - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Castle Biosciences|Rasio likuiditas perantara castlebiosciences.com

- rincian bathi lan kelipatan pasar:

CSTL - Bathi resik perusahaan|Bathi sing dikarepake Castle Biosciences|CSTL - Pangali P/E|Rasio prakiraan rega marang bathi castlebiosciences.com|CSTL - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Castle Biosciences, Inc.|CSTL - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Castle Biosciences|CSTL - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan castlebiosciences.com|CSTL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Castle Biosciences

- statistik dodolan lan pendapatan perusahaan:

CSTL - Pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Castle Bio|CSTL - Multiplikator P/S|Multiplikator forward rega marang pendapatan Castle Biosciences, Inc.

Ringkesan analisis perusahaan:CSTL, Castle Bio

Produk asil prodhuksi Castle Biosciences Corp

Castle Biosciences dominates the skin oncology diagnostics niche through its unique patented tests. Revenue measures the total volume of services rendered, reflecting the efficiency of its intellectual property monetization. Investors must compare sales growth rates with the share price to identify any overvaluation of the asset. The risk of capital drawdown is minimized once a sustainable expansion of market share is confirmed. This product sales trend confirms the fundamental resilience of the business.

Analisis perusahaan pesaing

Pendapatan perusahaan CAI|Dodolan perusahaan GH (Guardant Health, Inc.)|VCYT - Total pendapatan perusahaan|Pendapatan perusahaan Celcuity CELC|Pendapatan reged perusahaan GRAIL Inc (GRAL)|Myriad Genetics Corp - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Burning Rock Biotech Ltd BNR|volition.com (VNRX) - Pendapatan perusahaan|BDSX - Pendapatan reged perusahaan|PRPO (Precipio) - Pendapatan lan volume dodolan|Dodolan perusahaan Check-Cap Medical (CHEK)|Pendapatan lan volume dodolan MYNZ|Pendapatan lan volume dodolan OncoCyte Inc (OCX)